Home/Pipeline/Monoclonal Antibody Portfolio

Monoclonal Antibody Portfolio

Various oncology targets

PreclinicalActive

Key Facts

Indication
Various oncology targets
Phase
Preclinical
Status
Active
Company

About Etana Biotechnologies

Affordable Indonesian biopharma focused on recombinant proteins, biosimilars, and future monoclonal antibodies.

View full company profile

Other Various oncology targets Drugs

DrugCompanyPhase
Oncology PipelineJazz PharmaceuticalsPre-Clinical to Clinical
Switch-DARPin PlatformMolecular PartnersDiscovery/Preclinical
Radio-DARPin PlatformMolecular PartnersDiscovery/Preclinical